CONTENTS:
- Explaining the differences in opioid overdose deaths between Scotland and England/Wales: Implications for European opioid policies. van Amsterdam J., van den Brink W., Pierce M., p. 399-412.
- Motivational interviewing for cannabis use disorders: A systematic review and meta-analysis. Calomarde-Gomez C., Jiménez-Fernandez B., Balcells-Olivero M., Gual A., Lopez-Pelayo H., p. 413-427.
- Metabolic dynamics in the prefrontal cortex during a working memory task in young adult smokers. Bagga D., Cecchetto C., Aigner C.S., Tiraspolski I., Koschutnig K., Fischmeister F.P.S., et al., p. 428-438.
- Smokers "context reactivity" in virtual domestic environments. Benvegnù G., Tommasi F., Ferraro S., Libener E., Di Chio M., Bosi S., et al., p. 439-446.
- Prevalence and sociodemographic determinants of substance use in Turkey. Ünübol H., Hizli Sayar G., p. 447-456.
- Cabergoline in treatment of methamphetamine-dependent patients and its effect on serum level of glial cell-derived neurotrophic factor: A randomized, double-blind, placebo-controlled clinical trial. Alipour M., Jafarian M., Rastgoo R., Mokri A., Gorji A., Zarrindast M.R., et al., p. 457-468.
- Changes in online psychoactive substance trade via Telegram during the COVID-19 pandemic. Blankers M., van der Gouwe D., Stegemann L., Smit-Rigter L., p. 469-474.